| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,273 |
6,531 |
$208K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
520 |
495 |
$56K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
673 |
640 |
$27K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
360 |
330 |
$18K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,508 |
1,426 |
$9K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
149 |
149 |
$7K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
68 |
61 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
262 |
253 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
52 |
47 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
222 |
71 |
$1K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
18 |
18 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
131 |
71 |
$259.50 |
| 99050 |
|
9,528 |
7,419 |
$0.00 |
| 97802 |
|
12 |
12 |
$0.00 |
| 90723 |
|
15 |
15 |
$0.00 |
| 90686 |
|
26 |
26 |
$0.00 |
| 90647 |
|
14 |
14 |
$0.00 |
| 98960 |
|
436 |
329 |
$0.00 |
| G9920 |
Screening performed and negative |
173 |
166 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
45 |
45 |
$0.00 |
| 90670 |
|
17 |
17 |
$0.00 |